Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anvar Babaev

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Lancet (London, England)|September 29, 2018
A polymer-coated, paclitaxel-eluting stent (Eluvia) versus a polymer-free, paclitaxel-coated stent (Zilver PTX) for endovascular femoropopliteal intervention (IMPERIAL): a randomised, non-inferiority trialWilliam A Gray, Koen Keirse, Yoshimitsu Soga, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|July 3, 2026
Incidence and prognostic value of electrocardiographic changes in patients with myocardial injury after elective PCIAlexander LaRaja, Ashish Chakraborty, Nina Talmor, et al.
Clinical Cardiology|August 25, 2010
Sex and race are associated with the absence of epicardial coronary artery obstructive disease at angiography in patients with acute coronary syndromesNeel P Chokshi, Sohah N Iqbal, Rachel L Berger, et al.
Vascular|December 4, 2018
Bivalirudin versus heparin in patients undergoing percutaneous peripheral interventions: A systematic review and meta-analysisWilman Olmedo, Pedro A Villablanca, Cristina Sanina, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Lancet (London, England)|September 29, 2018
A polymer-coated, paclitaxel-eluting stent (Eluvia) versus a polymer-free, paclitaxel-coated stent (Zilver PTX) for endovascular femoropopliteal intervention (IMPERIAL): a randomised, non-inferiority trialWilliam A Gray, Koen Keirse, Yoshimitsu Soga, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|July 3, 2026
Incidence and prognostic value of electrocardiographic changes in patients with myocardial injury after elective PCIAlexander LaRaja, Ashish Chakraborty, Nina Talmor, et al.
Clinical Cardiology|August 25, 2010
Sex and race are associated with the absence of epicardial coronary artery obstructive disease at angiography in patients with acute coronary syndromesNeel P Chokshi, Sohah N Iqbal, Rachel L Berger, et al.
Vascular|December 4, 2018
Bivalirudin versus heparin in patients undergoing percutaneous peripheral interventions: A systematic review and meta-analysisWilman Olmedo, Pedro A Villablanca, Cristina Sanina, et al.
Pageof 3